Caveolin-1 Expression in Breast Cancer
Author Information
Author(s): Liedtke Cornelia, Kersting Christian, Bürger Horst, Kiesel Ludwig, Wülfing Pia
Primary Institution: University of Münster
Hypothesis
What is the clinical relevance of Caveolin-1 in benign and malignant breast tissue?
Conclusion
Caveolin-1 is expressed in about one third of invasive breast cancers, but its expression does not correlate with survival outcomes.
Supporting Evidence
- Caveolin-1 was not expressed in normal breast tissue or benign breast disease.
- Caveolin-1 expression was found in 32 of 109 cases of invasive breast carcinomas.
- No correlation was found between Caveolin-1 expression and survival parameters.
Takeaway
Caveolin-1 is a protein that can be found in some breast cancer cells, but it doesn't help doctors predict how well a patient will do.
Methodology
The study used tissue microarray technology to evaluate Caveolin-1 expression in various breast tissue samples.
Limitations
The study did not find significant correlations between Caveolin-1 expression and clinical outcomes.
Participant Demographics
The median age of patients was 59 years, with a range from 18 to 94 years.
Statistical Information
P-Value
0.008
Confidence Interval
95% CI 77–90
Statistical Significance
p=0.008
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website